Suppr超能文献

细针抽吸术联合液基细胞学在甲状腺病变外科处理中的作用。

The role of fine-needle aspiration performed with liquid-based cytology in the surgical management of thyroid lesions.

机构信息

Unit of Endocrinosurgery, Catholic University of Sacred Heart, Rome, Italy.

出版信息

In Vivo. 2010 May-Jun;24(3):333-7.

Abstract

BACKGROUND

The aim of this retrospective study was to assess the accuracy and usefulness of cytological classification of fine-needle aspirates in determining the appropriate surgical treatment for thyroid lesions studied with conventional smears (CS) and liquid-based cytology (LBC) in a split-sample method.

PATIENTS AND METHODS

A total of 353 patients were studied with both CS and LBC. The cytological diagnoses were classified according to the British Thyroid Association into 5 groups: Thy1, inadequate; Thy2, non-neoplastic or benign group including goiter, thyrocytic hyperplasia without nuclear atypia and thyroiditis; Thy3 or indeterminate/follicular proliferation, including follicular neoplasm not otherwise specified and oxyphilic follicular neoplasm; Thy4, suspicious for malignancy, including follicular lesion with nuclear pleomorphism; Thy5, diagnostic for malignancy including papillary carcinoma and medullary carcinoma. The efficacy of thyroid fine-needle aspiration processed by CS with LBC in a split-sample method was evaluated.

RESULTS

Overall 164 patients were included in the Thy2, 97 in the Thy3, 49 in the Thy4, and 43 in the malignant Thy5 group. The percentage of unnecessary thyroidectomies decreased from 58.5 to 42% in our series.

CONCLUSION

Our subclassification, according to the British Thyroid Association classification, attempts to reduce the number of Thy3 who undergo surgery. The comparison between the traditional management of thyroid lesions and our morphological categories with the use of CS and LBC together allows the number of unnecessary thyroidectomies to be reduced.

摘要

背景

本回顾性研究旨在评估细针抽吸细胞学分类在确定甲状腺病变的适当手术治疗方面的准确性和实用性,这些病变通过传统涂片(CS)和液基细胞学(LBC)以分样法进行研究。

患者和方法

共对 353 例患者进行了 CS 和 LBC 检查。细胞学诊断根据英国甲状腺协会(British Thyroid Association)分为 5 组:Thy1,不足;Thy2,非肿瘤或良性组,包括甲状腺肿、无核异型性的甲状腺细胞增生和甲状腺炎;Thy3 或不确定/滤泡增生,包括未特指的滤泡肿瘤和嗜酸细胞滤泡肿瘤;Thy4,疑恶性,包括核多形性滤泡病变;Thy5,诊断为恶性,包括甲状腺癌和髓样癌。评估了 CS 和 LBC 分样法处理甲状腺细针抽吸的效果。

结果

总体上,164 例患者归入 Thy2 组,97 例归入 Thy3 组,49 例归入 Thy4 组,43 例归入恶性 Thy5 组。在我们的研究中,不必要的甲状腺切除术的比例从 58.5%降至 42%。

结论

我们的亚分类,根据英国甲状腺协会的分类,试图减少需要手术的 Thy3 比例。将传统的甲状腺病变处理方法与我们的形态学分类进行比较,同时使用 CS 和 LBC,可减少不必要的甲状腺切除术数量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验